Advertisement

Topics

Merger looks to create bacteriophages to counter antibiotic resistance

05:44 EDT 14 May 2019 | BioPharma-Reporter

AmpliPhi Biosciences and C3J Therapeutics merge to focus on the development of phage-based therapeutic candidates for antibiotic resistance.

Original Article: Merger looks to create bacteriophages to counter antibiotic resistance

NEXT ARTICLE

More From BioPortfolio on "Merger looks to create bacteriophages to counter antibiotic resistance"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

MRSA (methicillin-resistant Staphylococcus aureus)
MRSA (methicillin-resistant Staphylococcus aureus) is a family of bacteria with resistance to one or more major antibiotics. There are currently 17 different strains of MRSA. Two particular strains, EMRSA15 and EMRSA16  account for 96% of MRSA blood...